|
Eveia Medical, Inc. is developing a series of testing systems to enable physicians and researchers to better understand and manage disease. Eveia’s biomarker discovery system provides a long-sought technology — enabling, sensitive, rapid and reliable measurement of virtually any biomarker — to the research community and eventually the clinical laboratory. Eveia’s Rapid Testing (Point-of-Care) technology enables cost effective management of many of the most common disease states, while eliminating need for expensive instrumentation and trained users. Systems include quantitative tests for anemia, anticoagulation therapy, therapeutic drug management and others. The company will aggressively pursue licensing technologies into additional markets with established companies in order to realize the full economic benefits of core technologies.
It is commonly accepted that maximum profitability in the Life Science and Clinical Diagnostics fields can be achieved by meeting the demand for innovative methods to perform tests faster, better or cheaper. Eveia Medical, Inc. is poised to introduce its lead products to accomplish these objectives in multibillion-dollar markets.
|
